\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ within\\ normal\\ limits\\ except\\ for\\ tenderness\\ throughout\\ the\\ abdomen\\ with\\ rebound\\.\\ on\\ pelvic\\ exam\\ cervical\\ motion\\ tenderness\\ was\\ absent\\;but\\,\\ there\\ is\\ a\\ mucopurulent\\ discharge\\ from\\ the\\ cervical\\ os\\.\ \(0\)\
\-\ labs\\:\\ \ \(3\)\
\-\ 1\\.lipase\\:\\ 2044\\(outside\\ facility\\)\\ down\\ to\\ 21\\ second\\ day\\ of\\ admission\\ \ \(0\)\
\-\ 2\\.amylase\\:125\ \(0\)\
\-\ 3\\.urinalysis\\:positive\\ for\\ leukocyte\\ esterase\ \(0\)\
\-\ 4\\.urine\\ culture\\:day\\ 1\\ grew\\ 30\\,000\\ \\-\\ 40\\,000\\ group\\ b\\ strep\ \(0\)\
\-\ pcr\\ for\\ chlamydia\\:positive\ \(0\)\
\-\ pcr\\ for\\ gonorrhea\\:positive\ \(0\)\
\-\ rpr\\:\\ non\\ reactive\ \(0\)\
\-\ hiv\\:\\ negative\ \(0\)\
\-\ bmp\\:\\ wnl\ \(0\)\
\-\ lipid\\ panel\\:\\ total\\ cholesterol\\:\\ 78\\,\\ tg\\ 42\\,\\ hdl\\ 30\\,\\ vldl\\ 8\ \(0\)\
\-\ mrcp\\ showed\\ no\\ signs\\ of\\ pancreatitis\\ \\-\\ but\\ with\\ fluid\\ in\\ the\\ pericholecystic\\ space\\ and\\ in\\ the\\ right\\ paracolic\\ gutter\\.\\ given\\ these\\ findings\\,\\ a\\ diagnosis\\ of\\ fitz\\-hugh\\-curtis\\ syndrome\\ was\\ established\\.\\ the\\ patient\\ was\\ started\\ on\\ iv\\ cefoxitine\\ and\\ po\\ doxycycline\\.\\ her\\ abdominal\\ pain\\ resolved\\ after\\ 24\\ hours\\ of\\ cefoxitine\\,\\ and\\ she\\ was\\ discharged\\ with\\ 12\\ days\\ remaining\\ of\\ 100mg\\ of\\ oral\\ doxycycline\\ twice\\ daily\\.\\ this\\ was\\ reported\\ to\\ the\\ county\\ health\\ board\\ to\\ try\\ to\\ get\\ hold\\ of\\ the\\ sexual\\ contacts\\.\\ no\\ follow\\-up\\ at\\ this\\ time\\.\ \(0\)\
\-\ u\\/s\\:\\ mildly\\ distended\\ common\\ bile\\ duct\\.borderline\\ to\\ mild\\ splenomegaly\\.\ \(0\)\
\-\ mrcp\\ without\\ contrast\\:\\ a\\ small\\ right\\ pleural\\ effusion\\ and\\ a\\ small\\ amount\\ of\\ fluid\\ in\\ the\\ pericholecystic\\ space\\ and\\ also\\ in\\ the\\ right\\ paracolic\\ gutter\\.\ \(0\)\
\-\ of\\ note\\ there\\ is\\ no\\ evidence\\ of\\ fluid\\ around\\ the\\ pancreas\\ or\\ a\\ pancreatic\\ pseudocyst\\.\\ the\\ pancreatic\\ duct\\ is\\ not\\ prominent\\ of\\ the\\ common\\ duct\\ is\\ slightly\\ prominent\\ at\\ 5\\ mm\\.\ \(0\)\
\-\ fitz\\-hugh\\ curtis\\ syndrome\ \(0\)\
\-\ 1\\.cholelithiasis\ \(0\)\
\-\ 2\\.cholecystitis\ \(0\)\
\-\ 3\\.pleurisy\ \(0\)\
\-\ 4\\.pneumonia\ \(0\)\
\-\ 5\\.pulmonary\\ embolism\ \(0\)\
\-\ 6\\.rib\\ fracture\ \(0\)\
\-\ 7\\.pyelonephritis\ \(0\)\
\-\ 8\\.hepatitis\ \(0\)\
\-\ 9\\.perforated\\ ulcer\ \(0\)\
\-\ 10\\.subphrenic\\ abscess\ \(0\)\
\-\ 11\\.pancreatitis\\ \\(gall\\ stone\\ pancreatitis\\)\ \(0\)\
\-\ 12\\.appendicitis\ \(0\)\
\-\ 13\\.herpes\\ zoster\ \(0\)\
\-\ 14\\.pid\ \(0\)\
\-\ 13\\ y\\.o\\.\\ girl\\ was\\ awakened\\ out\\ of\\ sleep\\ at\\ 2\\ am\\ by\\ a\\ sharp\\ 10\\/10\\ stabbing\\ pain\\ that\\ radiated\\ to\\ her\\ back\\.\\ she\\ denied\\ fevers\\,\\ rigors\\,\\ or\\ vomiting\\.\\ \\ the\\ pain\\ remains\\ constant\\ since\\ developing\\.\\ she\\ was\\ referred\\ from\\ an\\ outside\\ facility\\ with\\ a\\ diagnosis\\ of\\ pancreatitis\\,\\ because\\ her\\ labs\\ there\\ were\\ reported\\ to\\ be\\ abnormal\\.\\ \\ \\(the\\ lipase\\ was\\ 2044\\ and\\ the\\ amylase\\ 125\\,\\ \\ 10\\-15\\ wbcs\\ and\\ moderate\\ leukesterase\\ on\\ ua\\.\\)\\ \\ \\ there\\ is\\ a\\ family\\ history\\ of\\ gallbladder\\ disease\\,\\ she\\ denies\\ alcohol\\ use\\,\\ and\\ no\\ family\\ history\\ of\\ cystic\\ fibrosis\\.\\ \\ she\\ \\ is\\ sexually\\ active\\,\\ but\\ denies\\ dysuria\\,\\ polyuria\\,\\ diarrhea\\,\\ dyspareunia\\,\\ vaginal\\ discharge\\.\\ \\ her\\ last\\ menses\\ was\\ 1\\ week\\ ago\\ and\\ was\\ normal\\.\\ \\ she\\ has\\ had\\ two\\ sexual\\ partners\\,\\ and\\ the\\ last\\ coitus\\ episode\\ was\\ 2\\ weeks\\ ago\\.\\ \\ her\\ mother\\ has\\ cad\\ diagnosed\\ under\\ 50\\ y\\.o\\.\\ and\\ is\\ believed\\ to\\ have\\ hyperlipidemia\\.\ \(0\)\
\-\ with\\ the\\ initial\\ lipase\\ of\\ 2044\\ the\\ admitting\\ team\\ was\\ concerned\\ for\\ possible\\ gall\\ stone\\ pancreatitis\\.\\ however\\,\\ repeat\\ lipase\\ was\\ down\\ to\\ 66\\,\\ postive\\ pcr\\ for\\ gc\\ and\\ chlyamydia\\,\\ and\\ the\\ findings\\ of\\ mrcp\\ \\(done\\ to\\ evaluate\\ pancreatitis\\)\\ the\\ diagnosis\\ of\\ fitz\\-hugh\\ curtis\\ syndrome\\ was\\ made\\.\\ \\ http\\:\\/\\/emedicine\\.medscape\\.com\\/article\\/256448\\-overview\ \(0\)\
\-\ http\\:\\/\\/www\\.ncbi\\.nlm\\.nih\\.gov\\/pmc\\/articles\\/pmc2773862\\/\ \(0\)\
\-\ http\\:\\/\\/www\\.ccjm\\.org\\/content\\/71\\/3\\/233\\.long\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pancreatitis\\:\\ 0\\.23905418247119187\ \(0\)\
\-\ was\\:\\ 0\\.19603151441117964\ \(0\)\
\-\ 2044\\:\\ 0\\.19275763183537492\ \(0\)\
\-\ curtis\\:\\ 0\\.17811152371541913\ \(0\)\
\-\ lipase\\:\\ 0\\.16929262097009637\ \(0\)\
\-\ the\\:\\ 0\\.1603372784287227\ \(0\)\
\-\ pcr\\:\\ 0\\.15320669975205753\ \(0\)\
\-\ mrcp\\:\\ 0\\.15018299787920988\ \(0\)\
\-\ she\\:\\ 0\\.14350019486550758\ \(0\)\
\-\ of\\:\\ 0\\.1415260049310912\ \(0\)\
\-\ cefoxitine\\:\\ 0\\.12850508789024995\ \(0\)\
\-\ her\\:\\ 0\\.12550306491675053\ \(0\)\
\-\ doxycycline\\:\\ 0\\.11302939978915824\ \(0\)\
\-\ paracolic\\:\\ 0\\.11085794415719\ \(0\)\
\-\ and\\:\\ 0\\.10792840792083573\ \(0\)\
\-\ sexual\\:\\ 0\\.1044910202901168\ \(0\)\
\-\ duct\\:\\ 0\\.10375593357593471\ \(0\)\
\-\ gutter\\:\\ 0\\.10326532770918771\ \(0\)\
\-\ to\\:\\ 0\\.10044292136462134\ \(0\)\
\-\ gall\\:\\ 0\\.09184209566694534\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.08989603009727898\ \(0\)\
\-\ http\\:\\ 0\\.0891098254559789\ \(0\)\
\-\ 125\\:\\ 0\\.08901533218902508\ \(0\)\
\-\ amylase\\:\\ 0\\.08528671978030558\ \(0\)\
\-\ facility\\:\\ 0\\.07968472749039729\ \(0\)\
\-\ positive\\:\\ 0\\.07942469595878014\ \(0\)\
\-\ is\\:\\ 0\\.0770201391545699\ \(0\)\
\-\ stone\\:\\ 0\\.07339806924430169\ \(0\)\
\-\ for\\:\\ 0\\.07306492272193699\ \(0\)\
\-\ pancreatic\\:\\ 0\\.07284558359479341\ \(0\)\
\-\ syndrome\\:\\ 0\\.07266434412469004\ \(0\)\
\-\ discharge\\:\\ 0\\.07205547492715739\ \(0\)\
\-\ fluid\\:\\ 0\\.06959278296172583\ \(0\)\
\-\ last\\:\\ 0\\.0653549211144221\ \(0\)\
\-\ down\\:\\ 0\\.06527555989961915\ \(0\)\
\-\ denies\\:\\ 0\\.06480855873315572\ \(0\)\
\-\ outside\\:\\ 0\\.06450560988789822\ \(0\)\
\-\ mucopurulent\\:\\ 0\\.06425254394512497\ \(0\)\
\-\ leukesterase\\:\\ 0\\.06425254394512497\ \(0\)\
\-\ partners\\:\\ 0\\.06425254394512497\ \(0\)\
\-\ coitus\\:\\ 0\\.06425254394512497\ \(0\)\
\-\ chlyamydia\\:\\ 0\\.06425254394512497\ \(0\)\
\-\ there\\:\\ 0\\.06394598513949501\ \(0\)\
\-\ prominent\\:\\ 0\\.06328616274195002\ \(0\)\
\-\ family\\:\\ 0\\.06321761478007203\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06248316916666336\ \(0\)\
\-\ 13\\:\\ 0\\.060603813857367364\ \(0\)\
\-\ but\\:\\ 0\\.05960348620168725\ \(0\)\
\-\ gonorrhea\\:\\ 0\\.05937050790513971\ \(0\)\
\-\ hdl\\:\\ 0\\.05937050790513971\ \(0\)\
\-\ vldl\\:\\ 0\\.05937050790513971\ \(0\)\
\-\ awakened\\:\\ 0\\.05937050790513971\ \(0\)\
\-\ ago\\:\\ 0\\.05879399386677703\ \(0\)\
\-\ reported\\:\\ 0\\.05787550396727507\ \(0\)\
\-\ county\\:\\ 0\\.05779884334361582\ \(0\)\
\-\ admitting\\:\\ 0\\.05779884334361582\ \(0\)\
\-\ cervical\\:\\ 0\\.05755166031714521\ \(0\)\
\-\ tg\\:\\ 0\\.05651469989457912\ \(0\)\
\-\ rigors\\:\\ 0\\.05651469989457912\ \(0\)\
\-\ dyspareunia\\:\\ 0\\.05651469989457912\ \(0\)\
\-\ postive\\:\\ 0\\.05651469989457912\ \(0\)\
\-\ gc\\:\\ 0\\.05651469989457912\ \(0\)\
\-\ labs\\:\\ 0\\.05567065989026411\ \(0\)\
\-\ 12\\:\\ 0\\.05493011597049732\ \(0\)\
\-\ 30\\:\\ 0\\.05481666640397678\ \(0\)\
\-\ sexually\\:\\ 0\\.05448847186515445\ \(0\)\
\-\ polyuria\\:\\ 0\\.05448847186515445\ \(0\)\
\-\ 100mg\\:\\ 0\\.05365889188401853\ \(0\)\
\-\ try\\:\\ 0\\.05365889188401853\ \(0\)\
\-\ zoster\\:\\ 0\\.05365889188401853\ \(0\)\
\-\ space\\:\\ 0\\.053487774985158804\ \(0\)\
\-\ no\\:\\ 0\\.05226104280989818\ \(0\)\
\-\ chlamydia\\:\\ 0\\.051632663854593856\ \(0\)\
\-\ stabbing\\:\\ 0\\.051632663854593856\ \(0\)\
\-\ day\\:\\ 0\\.05118473645007201\ \(0\)\
\-\ board\\:\\ 0\\.051068899917352514\ \(0\)\
\-\ hold\\:\\ 0\\.051068899917352514\ \(0\)\
\-\ cad\\:\\ 0\\.05054693603860973\ \(0\)\
\-\ tenderness\\:\\ 0\\.05039251125048568\ \(0\)\
\-\ esterase\\:\\ 0\\.04960643582516918\ \(0\)\
\-\ strep\\:\\ 0\\.04960643582516918\ \(0\)\
\-\ rpr\\:\\ 0\\.04960643582516918\ \(0\)\
\-\ wbcs\\:\\ 0\\.04877685584403326\ \(0\)\
\-\ leukocyte\\:\\ 0\\.04769112802804913\ \(0\)\
\-\ contacts\\:\\ 0\\.047363474105073126\ \(0\)\
\-\ radiated\\:\\ 0\\.047363474105073126\ \(0\)\
\-\ menses\\:\\ 0\\.04705038748653367\ \(0\)\
\-\ concerned\\:\\ 0\\.04705038748653367\ \(0\)\
\-\ splenomegaly\\:\\ 0\\.046750627814608585\ \(0\)\
\-\ lipid\\:\\ 0\\.04646310670212138\ \(0\)\
\-\ dysuria\\:\\ 0\\.04592104783347267\ \(0\)\
\-\ grew\\:\\ 0\\.04566489999862446\ \(0\)\
\-\ bmp\\:\\ 0\\.04566489999862446\ \(0\)\
\-\ pseudocyst\\:\\ 0\\.04566489999862446\ \(0\)\
\-\ common\\:\\ 0\\.04557047104701206\ \(0\)\
\-\ at\\:\\ 0\\.04552663328008395\ \(0\)\
\-\ twice\\:\\ 0\\.04517896325308469\ \(0\)\
\-\ cholesterol\\:\\ 0\\.04450766609451254\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.04409323543710056\ \(0\)\
\-\ get\\:\\ 0\\.04370184090548717\ \(0\)\
\-\ established\\:\\ 0\\.04333105586680665\ \(0\)\
\-\ constant\\:\\ 0\\.04333105586680665\ \(0\)\
\-\ pain\\:\\ 0\\.04313094732341511\ \(0\)\
\-\ believed\\:\\ 0\\.04297881801246945\ \(0\)\
\-\ team\\:\\ 0\\.04297881801246945\ \(0\)\
\-\ os\\:\\ 0\\.04264335989015279\ \(0\)\
\-\ panel\\:\\ 0\\.042168351446548395\ \(0\)\
\-\ small\\:\\ 0\\.04144979897897455\ \(0\)\
\-\ po\\:\\ 0\\.041170665891763915\ \(0\)\
\-\ sleep\\:\\ 0\\.0410390117934874\ \(0\)\
\-\ 78\\:\\ 0\\.04090977350356396\ \(0\)\
\-\ exam\\:\\ 0\\.04045073131271446\ \(0\)\
\-\ in\\:\\ 0\\.039979416605475646\ \(0\)\
\-\ right\\:\\ 0\\.03996149519631933\ \(0\)\
\-\ ulcer\\:\\ 0\\.039842363745198645\ \(0\)\
\-\ hiv\\:\\ 0\\.039733163275858074\ \(0\)\
\-\ health\\:\\ 0\\.039733163275858074\ \(0\)\
\-\ findings\\:\\ 0\\.03965839998875113\ \(0\)\
\-\ sharp\\:\\ 0\\.039519713935530346\ \(0\)\
\-\ with\\:\\ 0\\.03933626852369826\ \(0\)\
\-\ bile\\:\\ 0\\.03901278376406273\ \(0\)\
\-\ culture\\:\\ 0\\.038915633407472096\ \(0\)\
\-\ vaginal\\:\\ 0\\.03872526265157552\ \(0\)\
\-\ developing\\:\\ 0\\.03844901982682139\ \(0\)\
\-\ ua\\:\\ 0\\.03835929518434434\ \(0\)\
\-\ rebound\\:\\ 0\\.03827069918367475\ \(0\)\
\-\ remains\\:\\ 0\\.03827069918367475\ \(0\)\
\-\ group\\:\\ 0\\.03818320378292681\ \(0\)\
\-\ remaining\\:\\ 0\\.03818320378292681\ \(0\)\
\-\ daily\\:\\ 0\\.03809678197248418\ \(0\)\
\-\ diarrhea\\:\\ 0\\.03801140772494738\ \(0\)\
\-\ am\\:\\ 0\\.037927055948078596\ \(0\)\
\-\ pancreas\\:\\ 0\\.03776132385016752\ \(0\)\
\-\ wnl\\:\\ 0\\.037679897634788094\ \(0\)\
\-\ 66\\:\\ 0\\.037679897634788094\ \(0\)\
\-\ except\\:\\ 0\\.03744111920253883\ \(0\)\
\-\ alcohol\\:\\ 0\\.037134840983934374\ \(0\)\
\-\ episode\\:\\ 0\\.03676982204396667\ \(0\)\
\-\ has\\:\\ 0\\.03670380824374346\ \(0\)\
\-\ embolism\\:\\ 0\\.03642279179739671\ \(0\)\
\-\ on\\:\\ 0\\.03640286961741571\ \(0\)\
\-\ denied\\:\\ 0\\.036288629851778643\ \(0\)\
\-\ resolved\\:\\ 0\\.03609206018628594\ \(0\)\
\-\ gallbladder\\:\\ 0\\.03590082791865393\ \(0\)\
\-\ 42\\:\\ 0\\.03571465084503923\ \(0\)\
\-\ fevers\\:\\ 0\\.035473831175510256\ \(0\)\
\-\ repeat\\:\\ 0\\.03524097396192359\ \(0\)\
\-\ reactive\\:\\ 0\\.03448173154312526\ \(0\)\
\-\ discharged\\:\\ 0\\.03448173154312526\ \(0\)\
\-\ distended\\:\\ 0\\.03432916335713002\ \(0\)\
\-\ mother\\:\\ 0\\.03432916335713002\ \(0\)\
\-\ started\\:\\ 0\\.03384322661159025\ \(0\)\
\-\ fibrosis\\:\\ 0\\.03365786619855787\ \(0\)\
\-\ admission\\:\\ 0\\.033521978590997\ \(0\)\
\-\ under\\:\\ 0\\.033257824288099716\ \(0\)\
\-\ absent\\:\\ 0\\.03296166640054581\ \(0\)\
\-\ total\\:\\ 0\\.03292035666814194\ \(0\)\
\-\ normal\\:\\ 0\\.0328083948188521\ \(0\)\
\-\ mildly\\:\\ 0\\.03244266250889611\ \(0\)\
\-\ oral\\:\\ 0\\.032178272087753965\ \(0\)\
\-\ amount\\:\\ 0\\.032141299356216395\ \(0\)\
\-\ 21\\:\\ 0\\.03210451969465278\ \(0\)\
\-\ around\\:\\ 0\\.03206793109712771\ \(0\)\
\-\ done\\:\\ 0\\.0319592920921092\ \(0\)\
\-\ from\\:\\ 0\\.03191358677429876\ \(0\)\
\-\ limits\\:\\ 0\\.031746915524486975\ \(0\)\
\-\ pelvic\\:\\ 0\\.031406593811793386\ \(0\)\
\-\ slightly\\:\\ 0\\.03134045915514372\ \(0\)\
\-\ evaluate\\:\\ 0\\.031242407142124232\ \(0\)\
\-\ motion\\:\\ 0\\.031145701423593426\ \(0\)\
\-\ made\\:\\ 0\\.030987418601029663\ \(0\)\
\-\ use\\:\\ 0\\.03074133980175526\ \(0\)\
\-\ history\\:\\ 0\\.03070024975803222\ \(0\)\
\-\ hours\\:\\ 0\\.03062145113379848\ \(0\)\
\-\ pleural\\:\\ 0\\.030245334020641675\ \(0\)\
\-\ note\\:\\ 0\\.030245334020641675\ \(0\)\
\-\ moderate\\:\\ 0\\.030161317646481806\ \(0\)\
\-\ second\\:\\ 0\\.030078291665228112\ \(0\)\
\-\ effusion\\:\\ 0\\.02983492925026948\ \(0\)\
\-\ active\\:\\ 0\\.02983492925026948\ \(0\)\
\-\ vomiting\\:\\ 0\\.02972940983572418\ \(0\)\
\-\ referred\\:\\ 0\\.02972940983572418\ \(0\)\
\-\ throughout\\:\\ 0\\.029548471356017264\ \(0\)\
\-\ since\\:\\ 0\\.02910348408154861\ \(0\)\
\-\ diagnosed\\:\\ 0\\.02910348408154861\ \(0\)\
\-\ mm\\:\\ 0\\.028752999379475425\ \(0\)\
\-\ iv\\:\\ 0\\.028707558646476092\ \(0\)\
\-\ 24\\:\\ 0\\.028484651144583116\ \(0\)\
\-\ girl\\:\\ 0\\.028183977294035913\ \(0\)\
\-\ signs\\:\\ 0\\.02807963036056054\ \(0\)\
\-\ because\\:\\ 0\\.02807963036056054\ \(0\)\
\-\ 50\\:\\ 0\\.028058945208587628\ \(0\)\
\-\ or\\:\\ 0\\.027954062694995035\ \(0\)\
\-\ given\\:\\ 0\\.027638026030049494\ \(0\)\
\-\ this\\:\\ 0\\.027611414236283917\ \(0\)\
\-\ possible\\:\\ 0\\.027222483654667517\ \(0\)\
\-\ week\\:\\ 0\\.027023558542849904\ \(0\)\
\-\ initial\\:\\ 0\\.02695259281217255\ \(0\)\
\-\ back\\:\\ 0\\.02679548691152385\ \(0\)\
\-\ showed\\:\\ 0\\.026761045330989747\ \(0\)\
\-\ out\\:\\ 0\\.026409226483118314\ \(0\)\
\-\ abscess\\:\\ 0\\.02579910434243994\ \(0\)\
\-\ days\\:\\ 0\\.025434085402472238\ \(0\)\
\-\ negative\\:\\ 0\\.024873605815574545\ \(0\)\
\-\ abdomen\\:\\ 0\\.024514960893403246\ \(0\)\
\-\ cystic\\:\\ 0\\.024197531926277202\ \(0\)\
\-\ abnormal\\:\\ 0\\.02413809453401582\ \(0\)\
\-\ weeks\\:\\ 0\\.024079154531619715\ \(0\)\
\-\ two\\:\\ 0\\.023859575642289438\ \(0\)\
\-\ time\\:\\ 0\\.02381420808327959\ \(0\)\
\-\ however\\:\\ 0\\.023780373162242827\ \(0\)\
\-\ fracture\\:\\ 0\\.022834249563925255\ \(0\)\
\-\ evidence\\:\\ 0\\.02280480022826491\ \(0\)\
\-\ mild\\:\\ 0\\.02277547351337181\ \(0\)\
\-\ these\\:\\ 0\\.022688218987068052\ \(0\)\
\-\ abdominal\\:\\ 0\\.02197413189215745\ \(0\)\
\-\ physical\\:\\ 0\\.021785154260764123\ \(0\)\
\-\ without\\:\\ 0\\.02119211237149417\ \(0\)\
\-\ were\\:\\ 0\\.020710332185050737\ \(0\)\
\-\ have\\:\\ 0\\.020070857170298943\ \(0\)\
\-\ had\\:\\ 0\\.020017899859278453\ \(0\)\
\-\ contrast\\:\\ 0\\.019521419265685267\ \(0\)\
\-\ after\\:\\ 0\\.019490756225595374\ \(0\)\
\-\ non\\:\\ 0\\.019063399534109512\ \(0\)\
\-\ also\\:\\ 0\\.01889833712225756\ \(0\)\
\-\ within\\:\\ 0\\.018504510305656058\ \(0\)\
\-\ that\\:\\ 0\\.017435521436953757\ \(0\)\
\-\ by\\:\\ 0\\.017061689992869205\ \(0\)\
\-\ disease\\:\\ 0\\.01686508056297677\ \(0\)\
\-\ be\\:\\ 0\\.016298399143118224\ \(0\)\
\-\ not\\:\\ 0\\.01586111505127884\ \(0\)\
\-\ an\\:\\ 0\\.015363735103897252\ \(0\)\
\-\ patient\\:\\ 0\\.013067718664176099\ \(0\)\
